Regina Dutkowski

Summary

Affiliation: F. Hoffmann-La Roche Ltd

Publications

  1. ncbi Safety and pharmacology of oseltamivir in clinical use
    Regina Dutkowski
    Hoffmann La Roche, Nutley, New Jersey 07110, USA
    Drug Saf 26:787-801. 2003
  2. ncbi Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients
    Regina Dutkowski
    Clinical Development Virology, Hoffmann La Roche Inc, 340 Kingsland Street, Nutley, NJ 07110 1199, USA
    J Antimicrob Chemother 65:ii11-ii24. 2010
  3. ncbi Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic
    Penelope Ward
    Roche Products Ltd, Welwyn Garden City, Herts, UK
    J Antimicrob Chemother 55:i5-i21. 2005

Collaborators

  • Charles Oo
  • Penelope Ward
  • Ian Small
  • James Smith
  • Pia Suter

Detail Information

Publications3

  1. ncbi Safety and pharmacology of oseltamivir in clinical use
    Regina Dutkowski
    Hoffmann La Roche, Nutley, New Jersey 07110, USA
    Drug Saf 26:787-801. 2003
    ..To conclude, no important safety concerns have evolved which might limit the suitability of oseltamivir for the treatment and prevention of influenza in all patient populations...
  2. ncbi Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients
    Regina Dutkowski
    Clinical Development Virology, Hoffmann La Roche Inc, 340 Kingsland Street, Nutley, NJ 07110 1199, USA
    J Antimicrob Chemother 65:ii11-ii24. 2010
    ..Oseltamivir-susceptible pandemic (H1N1) 2009 viruses now predominate in many countries. Oseltamivir is generally well tolerated, with a similar adverse event profile to placebo...
  3. ncbi Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic
    Penelope Ward
    Roche Products Ltd, Welwyn Garden City, Herts, UK
    J Antimicrob Chemother 55:i5-i21. 2005
    ..In the absence of a stockpile, there is no guarantee that an adequate supply of oseltamivir will be available...